Replies to post #116497 on Avid Bioservices Inc (CDMO)

[cjgaddy]

BW, could it be because it’s (Stifel) not being webcast? Was it listed on the Events page previously?

2-26-13: “Peregrine Announces Participation at Upcoming Investor Conferences”
http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=743395
TUSTIN, 2/26/13 -- Peregrine Pharmaceuticals, a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today announced that Steven W. King, President and CEO, will participate at the following investor conferences:

• 33rd Annual Cowen Health Care Conference *WEBCAST*
Tuesday, March 5, 2013, at 10:40amET
Marriott Copley Hotel Boston, Massachusetts

• 25th Annual ROTH Conference *WEBCAST*
Monday, March 18, 2013, at 2:00pmPT
The Ritz Carlton Hotel Dana Point, CA

• Stifel Nicolaus & Co. Biotechnology Investor Day
Wednesday, March 20, 2013
San Francisco, CA

Peregrine's presentations at the Cowen & Roth Conferences will be webcast live and available for replay until April 12, 2013 and April 25, 2013, respectively at: http://ir.peregrineinc.com/events.cfm .

[cheynew]

I googled the conference and couldn't find an agenda posted to see if PPHM is on. PPHM pr'd it 2/26, only a couple of weeks ago. If they dropped out, then why? Let's not have any more cancellations, deja vu September 2012.

[Protector]

It has NEVER been included. It is one of the pages I follow DAILY!

[cjgaddy]

BigW, IR said Stifel on (Mar20) as PR’d on 2-26-13 – it’s not on the Events page because it’s not being webcast. It's basically an “Investor Bus Tour” – was included in the Feb26 PR to garner interest from institutions…

Mar20 2013: Stifel Nicolaus Biotechnology Investor Day, SanFran
http://www.stifel.com/research
S.King participating (no webcast)

= = = = = = = = = = = = = = = = = = =
2-26-13: “Peregrine Announces Participation at Upcoming Investor Conferences”
http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=743395
TUSTIN, 2/26/13 -- Peregrine Pharmaceuticals, a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today announced that Steven W. King, President and CEO, will participate at the following investor conferences:

• 33rd Annual Cowen Health Care Conference *WEBCAST*
Tuesday, March 5, 2013, at 10:40amET => SLIDES & Excerpts: http://tinyurl.com/bczyfb3
Marriott Copley Hotel Boston

• 25th Annual ROTH Conference *WEBCAST*
Monday, March 18, 2013, at 2:00pmPT => http://ir.peregrineinc.com/events.cfm
The Ritz Carlton Hotel Dana Point, CA

• Stifel Nicolaus & Co. Biotechnology Investor Day (no webcast)
Wednesday, March 20, 2013
San Francisco, CA

Peregrine's presentations at the Cowen & Roth Conferences will be webcast live and available for replay until April 12, 2013 and April 25, 2013, respectively at: http://ir.peregrineinc.com/events.cfm .